Your browser doesn't support javascript.
loading
Eligibility and efficacy of a CPC- and CHX-based antiviral mouthwash for the elimination of SARS-CoV-2 from the saliva: A randomized, double-blind, controlled clinical trial.
Brunello, Giulia; Wolf, Viktoria; Kerberger, Robert; Bernhard, Michael; Lübke, Nadine; Becker, Jürgen; Schwarz-Herzke, Beryl; Timm, Jörg; Becker, Kathrin.
Afiliação
  • Brunello G; Department of Oral Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Wolf V; Department of Neurosciences, Dentistry Section, University of Padua, Padua, Italy.
  • Kerberger R; Department of Oral Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Bernhard M; Department of Orthodontics and Dentofacial Orthopaedics, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Lübke N; Department of Orthodontics, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Becker J; Emergency Department, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Schwarz-Herzke B; Institute of Virology, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
  • Timm J; Department of Oral Surgery, University Hospital Düsseldorf, Düsseldorf, Germany.
  • Becker K; Institute for Anatomy II, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.
J Clin Periodontol ; 51(2): 158-166, 2024 02.
Article em En | MEDLINE | ID: mdl-38058254
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / COVID-19 / Antissépticos Bucais Limite: Humans Idioma: En Revista: J Clin Periodontol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / COVID-19 / Antissépticos Bucais Limite: Humans Idioma: En Revista: J Clin Periodontol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha